GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elutia Inc (NAS:ELUT) » Definitions » Piotroski F-Score

Elutia (Elutia) Piotroski F-Score : 2 (As of Apr. 28, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Elutia Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 2 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Elutia has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Elutia's Piotroski F-Score or its related term are showing as below:

ELUT' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 2   Max: 3
Current: 2

During the past 6 years, the highest Piotroski F-Score of Elutia was 3. The lowest was 2. And the median was 2.


Elutia Piotroski F-Score Historical Data

The historical data trend for Elutia's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elutia Piotroski F-Score Chart

Elutia Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial N/A N/A 3.00 2.00 2.00

Elutia Quarterly Data
Dec18 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 3.00 3.00 2.00 2.00

Competitive Comparison of Elutia's Piotroski F-Score

For the Medical Devices subindustry, Elutia's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elutia's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Elutia's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Elutia's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was -7.974 + -10.621 + -9.747 + -9.314 = $-37.66 Mil.
Cash Flow from Operations was -5.166 + -2.389 + -5.123 + -9.083 = $-21.76 Mil.
Revenue was 13.05 + 10.296 + 6.127 + 5.875 = $35.35 Mil.
Gross Profit was 6.331 + 0.98 + 2.841 + 2.126 = $12.28 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(68.841 + 60.63 + 52.329 + 54.58 + 43.428) / 5 = $55.9616 Mil.
Total Assets at the begining of this year (Dec22) was $68.84 Mil.
Long-Term Debt & Capital Lease Obligation was $20.36 Mil.
Total Current Assets was $31.25 Mil.
Total Current Liabilities was $43.04 Mil.
Net Income was -8.149 + -9.398 + -9.91 + -5.44 = $-32.90 Mil.

Revenue was 11.495 + 12.638 + 5.849 + 6.587 = $36.57 Mil.
Gross Profit was 4.281 + 4.898 + 2.939 + 3.066 = $15.18 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(67.17 + 59.926 + 52.854 + 61.022 + 68.841) / 5 = $61.9626 Mil.
Total Assets at the begining of last year (Dec21) was $67.17 Mil.
Long-Term Debt & Capital Lease Obligation was $24.26 Mil.
Total Current Assets was $50.70 Mil.
Total Current Liabilities was $42.62 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Elutia's current Net Income (TTM) was -37.66. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Elutia's current Cash Flow from Operations (TTM) was -21.76. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-37.656/68.841
=-0.54699961

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-32.897/67.17
=-0.48975733

Elutia's return on assets of this year was -0.54699961. Elutia's return on assets of last year was -0.48975733. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Elutia's current Net Income (TTM) was -37.66. Elutia's current Cash Flow from Operations (TTM) was -21.76. ==> -21.76 > -37.66 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=20.356/55.9616
=0.36374943

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=24.26/61.9626
=0.3915265

Elutia's gearing of this year was 0.36374943. Elutia's gearing of last year was 0.3915265. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=31.253/43.037
=0.72618909

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=50.699/42.615
=1.18969846

Elutia's current ratio of this year was 0.72618909. Elutia's current ratio of last year was 1.18969846. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Elutia's number of shares in issue this year was 23.251. Elutia's number of shares in issue last year was 14.476. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=12.278/35.348
=0.34734638

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=15.184/36.569
=0.41521507

Elutia's gross margin of this year was 0.34734638. Elutia's gross margin of last year was 0.41521507. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=35.348/68.841
=0.51347308

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=36.569/67.17
=0.54442459

Elutia's asset turnover of this year was 0.51347308. Elutia's asset turnover of last year was 0.54442459. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+0+0+0+0
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Elutia has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

Elutia  (NAS:ELUT) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Elutia Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Elutia's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Elutia (Elutia) Business Description

Traded in Other Exchanges
N/A
Address
12510 Prosperity Drive, Suite 370, Silver Spring, MD, USA, 20904
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health, Orthobiologics, and Cardiovascular. It generates maximum revenue from the Orthobiologics segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
Executives
Elutia Pipe Investment, Lp 10 percent owner 36 CHURCH LANE, WESTPORT CT 06880
Birchview Fund Llc 10 percent owner 688 PINE STREET, BURLINGTON VT 05401
Thomas Englese officer: Chief Commercial Officer C/O AZIYO BIOLOGICS, INC., 12510 PROSPERITY DRIVE, SUITE 370, SILVER SPRING MD 20904
David Colpman director 452 FIFTH AVENUE, NEW YORK NY 10018
Brigid Makes director 20245 SW 95TH AVENUE, TUALATIN OR 97062
Matthew Ferguson officer: Chief Financial Officer C/O FOXHOLLOW TECHNOLOGIES, INC., 740 BAY ROAD, REDWOOD CITY CA 94063
Highcape Partners Gp Ii, Llc 10 percent owner 36 CHURCH LANE, WESTPORT CT 06880
Highcape Partners Gp Ii, L.p. 10 percent owner 36 CHURCH LANE, WESTPORT CT 06880
Highcape Partners Qp Ii, L.p. 10 percent owner 36 CHURCH LANE, WESTPORT CT 06880
Highcape Partners Ii, L.p. 10 percent owner 36 CHURCH LANE, WESTPORT CT 06880
Highcape Capital, L.p. 10 percent owner 36 CHURCH LANE, WESTPORT CT 06880
Michelle Leroux Williams officer: Chief Scientific Officer C/O AZIYO BIOLOGICS, INC., 12510 PROSPERITY DRIVE, SUITE 370, SILVER SPRINT MD 20904
Matthew Strobeck 10 percent owner C/O METABOLIX, INC., 21 ERIE STREET, CAMBRIDGE MA 02139
Birchview Capital, Lp 10 percent owner 688 PINE STREET, SUITE D, C/O BIRCHVIEW CAPITAL, BURLINGTON VT 05401
Peter G Edwards officer: GENERAL COUNSEL C/O BAXALTA INCORPORATED, 1200 LAKESIDE DRIVE, BANNOCKBURN IL 60015